Cardiovascular Risk in Essential Thrombocythemia and Polycythemia Vera: Thrombotic Risk and Survival

Thromboembolic and bleeding events pose a severe risk for patients with Polycythemia Vera (PV) and Essential Thrombocythemia (ET). Many factors can contribute to promoting the thrombotic event due to the interaction between platelets, leukocytes, and endothelium alterations. Moreover, a significant...

Full description

Saved in:
Bibliographic Details
Published in:Mediterranean journal of hematology and infectious diseases 2020, Vol.12 (1), p.e2020008-e2020008
Main Authors: Accurso, Vincenzo, Santoro, Marco, Mancuso, Salvatrice, Contrino, Angelo Davide, Casimiro, Paolo, Sardo, Mariano, Raso, Simona, Di Piazza, Florinda, Perez, Alessandro, Bono, Marco, Russo, Antonio, Siragusa, Sergio
Format: Article
Language:English
Subjects:
Essential Thrombocythemia
Original
Polycythemia Vera
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c456t-1f3d643c4e735f5d3eaaf36aa5e61741a5a8059af86dc120a69a6fa2d7e2a6cc3
cites
container_end_page e2020008
container_issue 1
container_start_page e2020008
container_title Mediterranean journal of hematology and infectious diseases
container_volume 12
creator Accurso, Vincenzo
Santoro, Marco
Mancuso, Salvatrice
Contrino, Angelo Davide
Casimiro, Paolo
Sardo, Mariano
Raso, Simona
Di Piazza, Florinda
Perez, Alessandro
Bono, Marco
Russo, Antonio
Siragusa, Sergio
description Thromboembolic and bleeding events pose a severe risk for patients with Polycythemia Vera (PV) and Essential Thrombocythemia (ET). Many factors can contribute to promoting the thrombotic event due to the interaction between platelets, leukocytes, and endothelium alterations. Moreover, a significant role can be played by cardiovascular risk factors (CV.R) such as cigarette smoking habits, hypertension, diabetes, obesity and dyslipidemia. In this study, we evaluated the impact that CV.R plays on thrombotic risk and survival in patients with PV and ET.
doi_str_mv 10.4084/MJHID.2020.008
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_ee0f15aa667547ed89c6929f8718e284</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_ee0f15aa667547ed89c6929f8718e284</doaj_id><sourcerecordid>2338056228</sourcerecordid><originalsourceid>FETCH-LOGICAL-c456t-1f3d643c4e735f5d3eaaf36aa5e61741a5a8059af86dc120a69a6fa2d7e2a6cc3</originalsourceid><addsrcrecordid>eNpVkU1vEzEQhi0EolXbK0e0Ry4J_l4vByQUCk1VBILC1Zr6o3Hwrlt7N1L-PQ5po9aXscfvPJ7xi9AbguccK_7-2-XF8vOcYornGKsX6JhiJmYMY_nyyf4InZWyxnUxRhSjr9ERIx3j9XCM7AKyDWkDxUwRcvMzlL9NGJrzUtwwBojN9Sqn_iaZ7bhyfYAGBtv8SHF7SPxxGT48ysZg9oyd7NeUN2ED8RS98hCLO3uIJ-j3l_PrxcXs6vvX5eLT1cxwIccZ8cxKzgx3LRNeWOYAPJMAwknScgICFBYdeCWtIRSD7EB6oLZ1FKQx7AQt91ybYK3vcughb3WCoP8nUr7VkGuH0WnnsCcCQMpW8NZZ1RnZ0c6rlihHFa-sj3vW3XTTO2vqb2SIz6DPb4aw0rdpo2UnCBO0At49AHK6n1wZdR-KcTHC4NJUNGWsTiMpVVU630tNTqVk5w_PEKx3Tut-vQpW75zW1ela8PZpcwf5o6_sH53Rpmg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2338056228</pqid></control><display><type>article</type><title>Cardiovascular Risk in Essential Thrombocythemia and Polycythemia Vera: Thrombotic Risk and Survival</title><source>PubMed Central</source><source>EZB Electronic Journals Library</source><creator>Accurso, Vincenzo ; Santoro, Marco ; Mancuso, Salvatrice ; Contrino, Angelo Davide ; Casimiro, Paolo ; Sardo, Mariano ; Raso, Simona ; Di Piazza, Florinda ; Perez, Alessandro ; Bono, Marco ; Russo, Antonio ; Siragusa, Sergio</creator><creatorcontrib>Accurso, Vincenzo ; Santoro, Marco ; Mancuso, Salvatrice ; Contrino, Angelo Davide ; Casimiro, Paolo ; Sardo, Mariano ; Raso, Simona ; Di Piazza, Florinda ; Perez, Alessandro ; Bono, Marco ; Russo, Antonio ; Siragusa, Sergio</creatorcontrib><description>Thromboembolic and bleeding events pose a severe risk for patients with Polycythemia Vera (PV) and Essential Thrombocythemia (ET). Many factors can contribute to promoting the thrombotic event due to the interaction between platelets, leukocytes, and endothelium alterations. Moreover, a significant role can be played by cardiovascular risk factors (CV.R) such as cigarette smoking habits, hypertension, diabetes, obesity and dyslipidemia. In this study, we evaluated the impact that CV.R plays on thrombotic risk and survival in patients with PV and ET.</description><identifier>ISSN: 2035-3006</identifier><identifier>EISSN: 2035-3006</identifier><identifier>DOI: 10.4084/MJHID.2020.008</identifier><identifier>PMID: 31934318</identifier><language>eng</language><publisher>Italy: Università Cattolica del Sacro Cuore</publisher><subject>Essential Thrombocythemia ; Original ; Polycythemia Vera</subject><ispartof>Mediterranean journal of hematology and infectious diseases, 2020, Vol.12 (1), p.e2020008-e2020008</ispartof><rights>2020</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c456t-1f3d643c4e735f5d3eaaf36aa5e61741a5a8059af86dc120a69a6fa2d7e2a6cc3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6951352/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6951352/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,4010,27904,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31934318$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Accurso, Vincenzo</creatorcontrib><creatorcontrib>Santoro, Marco</creatorcontrib><creatorcontrib>Mancuso, Salvatrice</creatorcontrib><creatorcontrib>Contrino, Angelo Davide</creatorcontrib><creatorcontrib>Casimiro, Paolo</creatorcontrib><creatorcontrib>Sardo, Mariano</creatorcontrib><creatorcontrib>Raso, Simona</creatorcontrib><creatorcontrib>Di Piazza, Florinda</creatorcontrib><creatorcontrib>Perez, Alessandro</creatorcontrib><creatorcontrib>Bono, Marco</creatorcontrib><creatorcontrib>Russo, Antonio</creatorcontrib><creatorcontrib>Siragusa, Sergio</creatorcontrib><title>Cardiovascular Risk in Essential Thrombocythemia and Polycythemia Vera: Thrombotic Risk and Survival</title><title>Mediterranean journal of hematology and infectious diseases</title><addtitle>Mediterr J Hematol Infect Dis</addtitle><description>Thromboembolic and bleeding events pose a severe risk for patients with Polycythemia Vera (PV) and Essential Thrombocythemia (ET). Many factors can contribute to promoting the thrombotic event due to the interaction between platelets, leukocytes, and endothelium alterations. Moreover, a significant role can be played by cardiovascular risk factors (CV.R) such as cigarette smoking habits, hypertension, diabetes, obesity and dyslipidemia. In this study, we evaluated the impact that CV.R plays on thrombotic risk and survival in patients with PV and ET.</description><subject>Essential Thrombocythemia</subject><subject>Original</subject><subject>Polycythemia Vera</subject><issn>2035-3006</issn><issn>2035-3006</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkU1vEzEQhi0EolXbK0e0Ry4J_l4vByQUCk1VBILC1Zr6o3Hwrlt7N1L-PQ5po9aXscfvPJ7xi9AbguccK_7-2-XF8vOcYornGKsX6JhiJmYMY_nyyf4InZWyxnUxRhSjr9ERIx3j9XCM7AKyDWkDxUwRcvMzlL9NGJrzUtwwBojN9Sqn_iaZ7bhyfYAGBtv8SHF7SPxxGT48ysZg9oyd7NeUN2ED8RS98hCLO3uIJ-j3l_PrxcXs6vvX5eLT1cxwIccZ8cxKzgx3LRNeWOYAPJMAwknScgICFBYdeCWtIRSD7EB6oLZ1FKQx7AQt91ybYK3vcughb3WCoP8nUr7VkGuH0WnnsCcCQMpW8NZZ1RnZ0c6rlihHFa-sj3vW3XTTO2vqb2SIz6DPb4aw0rdpo2UnCBO0At49AHK6n1wZdR-KcTHC4NJUNGWsTiMpVVU630tNTqVk5w_PEKx3Tut-vQpW75zW1ela8PZpcwf5o6_sH53Rpmg</recordid><startdate>2020</startdate><enddate>2020</enddate><creator>Accurso, Vincenzo</creator><creator>Santoro, Marco</creator><creator>Mancuso, Salvatrice</creator><creator>Contrino, Angelo Davide</creator><creator>Casimiro, Paolo</creator><creator>Sardo, Mariano</creator><creator>Raso, Simona</creator><creator>Di Piazza, Florinda</creator><creator>Perez, Alessandro</creator><creator>Bono, Marco</creator><creator>Russo, Antonio</creator><creator>Siragusa, Sergio</creator><general>Università Cattolica del Sacro Cuore</general><general>PAGEPress Publications</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>2020</creationdate><title>Cardiovascular Risk in Essential Thrombocythemia and Polycythemia Vera: Thrombotic Risk and Survival</title><author>Accurso, Vincenzo ; Santoro, Marco ; Mancuso, Salvatrice ; Contrino, Angelo Davide ; Casimiro, Paolo ; Sardo, Mariano ; Raso, Simona ; Di Piazza, Florinda ; Perez, Alessandro ; Bono, Marco ; Russo, Antonio ; Siragusa, Sergio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c456t-1f3d643c4e735f5d3eaaf36aa5e61741a5a8059af86dc120a69a6fa2d7e2a6cc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Essential Thrombocythemia</topic><topic>Original</topic><topic>Polycythemia Vera</topic><toplevel>online_resources</toplevel><creatorcontrib>Accurso, Vincenzo</creatorcontrib><creatorcontrib>Santoro, Marco</creatorcontrib><creatorcontrib>Mancuso, Salvatrice</creatorcontrib><creatorcontrib>Contrino, Angelo Davide</creatorcontrib><creatorcontrib>Casimiro, Paolo</creatorcontrib><creatorcontrib>Sardo, Mariano</creatorcontrib><creatorcontrib>Raso, Simona</creatorcontrib><creatorcontrib>Di Piazza, Florinda</creatorcontrib><creatorcontrib>Perez, Alessandro</creatorcontrib><creatorcontrib>Bono, Marco</creatorcontrib><creatorcontrib>Russo, Antonio</creatorcontrib><creatorcontrib>Siragusa, Sergio</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Mediterranean journal of hematology and infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Accurso, Vincenzo</au><au>Santoro, Marco</au><au>Mancuso, Salvatrice</au><au>Contrino, Angelo Davide</au><au>Casimiro, Paolo</au><au>Sardo, Mariano</au><au>Raso, Simona</au><au>Di Piazza, Florinda</au><au>Perez, Alessandro</au><au>Bono, Marco</au><au>Russo, Antonio</au><au>Siragusa, Sergio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cardiovascular Risk in Essential Thrombocythemia and Polycythemia Vera: Thrombotic Risk and Survival</atitle><jtitle>Mediterranean journal of hematology and infectious diseases</jtitle><addtitle>Mediterr J Hematol Infect Dis</addtitle><date>2020</date><risdate>2020</risdate><volume>12</volume><issue>1</issue><spage>e2020008</spage><epage>e2020008</epage><pages>e2020008-e2020008</pages><issn>2035-3006</issn><eissn>2035-3006</eissn><abstract>Thromboembolic and bleeding events pose a severe risk for patients with Polycythemia Vera (PV) and Essential Thrombocythemia (ET). Many factors can contribute to promoting the thrombotic event due to the interaction between platelets, leukocytes, and endothelium alterations. Moreover, a significant role can be played by cardiovascular risk factors (CV.R) such as cigarette smoking habits, hypertension, diabetes, obesity and dyslipidemia. In this study, we evaluated the impact that CV.R plays on thrombotic risk and survival in patients with PV and ET.</abstract><cop>Italy</cop><pub>Università Cattolica del Sacro Cuore</pub><pmid>31934318</pmid><doi>10.4084/MJHID.2020.008</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2035-3006
ispartof Mediterranean journal of hematology and infectious diseases, 2020, Vol.12 (1), p.e2020008-e2020008
issn 2035-3006
2035-3006
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_ee0f15aa667547ed89c6929f8718e284
source PubMed Central; EZB Electronic Journals Library
subjects Essential Thrombocythemia
Original
Polycythemia Vera
title Cardiovascular Risk in Essential Thrombocythemia and Polycythemia Vera: Thrombotic Risk and Survival
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T00%3A40%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cardiovascular%20Risk%20in%20Essential%20Thrombocythemia%20and%20Polycythemia%20Vera:%20Thrombotic%20Risk%20and%20Survival&rft.jtitle=Mediterranean%20journal%20of%20hematology%20and%20infectious%20diseases&rft.au=Accurso,%20Vincenzo&rft.date=2020&rft.volume=12&rft.issue=1&rft.spage=e2020008&rft.epage=e2020008&rft.pages=e2020008-e2020008&rft.issn=2035-3006&rft.eissn=2035-3006&rft_id=info:doi/10.4084/MJHID.2020.008&rft_dat=%3Cproquest_doaj_%3E2338056228%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c456t-1f3d643c4e735f5d3eaaf36aa5e61741a5a8059af86dc120a69a6fa2d7e2a6cc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2338056228&rft_id=info:pmid/31934318&rfr_iscdi=true